September 20, 2017 9:47 PM ET

Biotechnology

Company Overview of G1 Therapeutics, Inc.

Key Executives for G1 Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Mark A. Velleca M.D., Ph.D.12 RelationshipsChief Executive Officer, President and Director53
Jennifer K. Moses No RelationshipsVice President of Finance & Administration42
Rajesh K. Malik M.D., M.B., Ch.B.No RelationshipsChief Medical Officer58
Gregory J. Mossinghoff No RelationshipsChief Business Officer and Secretary56
Terry L. Murdock MScNo RelationshipsSenior Vice President of Development Operations--

G1 Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Seth A. Rudnick M.D. 100 RelationshipsG1 Therapeutics, Inc.68
Mark A. Velleca M.D., Ph.D. 12 RelationshipsG1 Therapeutics, Inc.53
Christy L. Shaffer Ph.D. 104 RelationshipsHatteras Venture Partners59
Glenn P. Muir 49 RelationshipsReWalk Robotics Ltd.58
Kwok-Kin Wong M.D., Ph.D. 12 RelationshipsNYU Langone Medical Center LLC--
View All Board Members

G1 Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Glenn P. Muir49 Relationships3 Executives
Compensation Committee Ph.D.Christy L. Shaffer104 Relationships3 Executives
Nominating Committee M.D.Seth A. Rudnick100 Relationships3 Executives
Corporate Governance Committee M.D.Seth A. Rudnick100 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$405.0K
405.0K
392.6K
Bonus$133.7K
133.7K
238.0K
Total Short Term Compensation
Not meaningful
Total Value of Options$538.7K
538.7K
18.4M
Compensation as of Fiscal Year 2016
G1 Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

VALBIOTIS Appoints Jean Zetlaoui on Valbiotis to Supervisory Board
September 20, 2017 5:30 AM ET
Sirtex Medical Limited Announces Board Changes
September 19, 2017 10:21 PM ET
FibroGen, Inc. Appoints Gerald Lema to Board of Directors
September 19, 2017 8:35 PM ET
Intarcia Therapeutics, Inc. Announces Board Changes
September 19, 2017 8:10 PM ET
GT Biopharma, Inc. Appoints Thomas N. Chase as Advisor to the Board of Directors
September 19, 2017 1:44 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact G1 Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.